Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Rui-jie Tang"'
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Cardiovascular diseases (CVDs) have been attracting the attention of academic society for decades. Numerous researchers contributed to figuring out the core mechanisms underlying CVDs. Among those, pathological decompensated cellular loss posed by ce
Externí odkaz:
https://doaj.org/article/20af8dc1e1424959aa33d33783713fe6
Autor:
Gui-hao Chen, Chuan-sheng Xu, Jie Zhang, Qing Li, He-he Cui, Xiang-dong Li, Li-ping Chang, Rui-jie Tang, Jun-yan Xu, Xia-qiu Tian, Pei-sen Huang, Jun Xu, Chen Jin, Yue-jin Yang
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
Background and Aims: Tongxinluo (TXL) is a multifunctional traditional Chinese medicine that has been widely used to treat cardiovascular and cerebrovascular diseases. However, no studies have explored whether TXL can protect human cardiomyocytes (HC
Externí odkaz:
https://doaj.org/article/aaf9aa2d42074d74bb582eff31815059
Autor:
Xu-Ping, Jiang, Yao-Xiang, Sun, Bin, Qiao, Wen-Jiao, Zhu, Yu-Jiao, Chu, Miao-Miao, Sun, Rui-Jie, Tang, Tie-Liang, Ma, Zhi-An, Tang
Publikováno v:
Chinese Journal of Natural Medicines. 20:580-588
Male infertility has evolved from a common reproductive system disease to a major social issue. Youjing granule (YG) is a Chinese medicinal material used as a therapy method for tonifying the kidneys and removing dampness due to its pathogenic charac
Autor:
Li-li Zhang, Gui-hao Chen, Rui-jie Tang, Yu-yan Xiong, Qi Pan, Wen-yang Jiang, Zhao-ting Gong, Cheng Chen, Xiao-song Li, Yue-jin Yang
Publikováno v:
Cardiovascular Drugs and Therapy.
Autor:
Xiao-Tong Lu, Yu Ning, Jing Xu, Rui-Jie Tang, Cun-Rong Huang, Chun-Xiao Wu, Yu-Yan Xiong, Chen Jin, Wen-Yang Jiang, Gui-Hao Chen, Xiangdong Li, Yi Xu, Meng-Jin Hu, Jun Xu, Pei-Sen Huang, Hai-Yan Qian, Yuejin Yang, Jun-Yan Xu, Zhao-Ting Gong
Publikováno v:
Cardiovascular Research. 118:2165-2178
Aims Interleukin (IL)-5 mediates the development of eosinophils (EOS) that are essential for tissue post-injury repair. It remains unknown whether IL-5 plays a role in heart repair after myocardial infarction (MI). This study aims to test whether IL-
Autor:
Joseph A. Hill, Yuejin Yang, Chen Jin, Cong Wei, Chuansheng Xu, Rui-Jie Tang, Guihao Chen, Jun Xu, Li-ping Chang, Xiangdong Li, Yu-Yan Xiong, Qing Li, Yu Ning, Cun-Rong Huang, Thomas G. Gillette, Pei-Sen Huang, Xia-Qiu Tian, Tongyi Huang, Qinfeng Li, Jun-Yan Xu
Publikováno v:
Theranostics
Rationale: The crosstalk between cardiac microvascular endothelial cells (CMECs) and cardiomyocytes (CMs) has emerged as a key component in the development of, and protection against, cardiac diseases. For example, activation of endothelial nitric ox
Publikováno v:
Journal of Visualized Experiments.
Revascularization therapies for culprit arteries, regardless of percutaneous coronary intervention and coronary artery bypass grafting, are considered the best strategy for improving the clinical prognosis of patients with acute coronary syndrome (AC
Publikováno v:
Circulation. 142
Background: Eosinophils have been commonly recognized as one of the major participants in helminth infection and allergic diseases. Recent studies suggest that these innate immune cells mediate tissue repairs after muscle, hepatic, or endometrial inj
Publikováno v:
Theranostics
Acute myocardial infarction (AMI) is one of the leading causes of mortality around the world, and the inflammatory response plays a pivotal role in the progress of myocardial necrosis and ventricular remodeling, dysfunction and heart failure after AM
Autor:
Bo Xu, Yuan Wu, Xi-Feng Jiang, Runlin Gao, Wen-Yang Jiang, Rui Shen, Shihua Zhao, Yuejin Yang, Wen-Xiu Leng, Yang Wang, Xiangfeng Lu, Yong-Jian Geng, Minjie Lu, Shu-Bin Qiao, Jun Zhang, Wei Li, Rui-Jie Tang, Jian-Wen Li, Hai-Yan Qian, Pei-Sen Huang, Jun Xu, Yu-Yan Xiong, Xiangdong Li, Gui-Hao Chen, Wei Fang, Chen Jin, Chen Xi, Jun-Yan Xu, Jie Qian, Chun-Cheng Ma, Weichun Wu, Yi Xu, Cun-Rong Huang, Meng-Jin Hu
Publikováno v:
Regenerative medicine. 14(12)
Aim: To determine the efficacy and safety of intracoronary infusion of autologous bone marrow mesenchymal stem cells (MSCINJ) in combination with intensive atorvastatin (ATV) treatment for patients with anterior ST-segment elevation myocardial infarc